Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HPGD | P15428 | 3/20 | 0.78 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.78 |
| ▸ | TSHR | P16473 | 1/20 | 0.78 |
| ▸ | HDAC2 | Q92769 | 7/20 | 0.58 |
| ▸ | HDAC1 | Q13547 | 6/20 | 0.58 |
| ▸ | HDAC3 | O15379 | 5/20 | 0.58 |
| ▸ | HDAC10 | Q969S8 | 4/20 | 0.58 |
| ▸ | HDAC8 | Q9BY41 | 4/20 | 0.58 |
| ▸ | HDAC6 | Q9UBN7 | 4/20 | 0.58 |
| ▸ | HDAC4 | P56524 | 3/20 | 0.58 |
| ▸ | HDAC7 | Q8WUI4 | 3/20 | 0.58 |
| ▸ | HDAC11 | Q96DB2 | 3/20 | 0.58 |
| ▸ | HDAC9 | Q9UKV0 | 3/20 | 0.58 |
| ▸ | HDAC5 | Q9UQL6 | 3/20 | 0.58 |
| ▸ | NCOR2 | Q9Y618 | 2/20 | 0.58 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.57 |
| ▸ | MMP13 | P45452 | 1/20 | 0.57 |
| ▸ | NPC1 | O15118 | 2/20 | 0.53 |
| ▸ | RAB9A | P51151 | 2/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL443041 | 1.00 | HPGD (0.78) | HPGDSMN1; SMN2TSHRHDAC2HDAC1 | |
| SCHEMBL446620 | 0.97 | HPGD (0.73) | HPGDSMN1; SMN2TSHRHDAC2HDAC1 | |
| SCHEMBL445825 | 0.93 | HPGD (0.68) | HPGDSMN1; SMN2TSHRHDAC2HDAC1 | |
| SCHEMBL4247735 | 0.90 | HPGD (0.73) | HPGDSMN1; SMN2TSHRHDAC2HDAC1 | |
| SCHEMBL445311 | 0.90 | SMN1; SMN2 (0.84) | HPGDSMN1; SMN2TSHRHDAC2HDAC1 | |
| SCHEMBL443880 | 0.88 | SMN1; SMN2 (0.61) | HPGDSMN1; SMN2TSHRHDAC2HDAC1 | |
| SCHEMBL4251140 | 0.87 | HPGD (0.69) | HPGDSMN1; SMN2TSHRHDAC2HDAC1 | |
| SCHEMBL446067 | 0.87 | HPGD (0.58) | HPGDSMN1; SMN2TSHRHDAC2HDAC1 | |
| SCHEMBL445805 | 0.86 | HDAC3 (0.63) | HPGDSMN1; SMN2TSHRHDAC2HDAC1 | |
| SCHEMBL443586 | 0.86 | HPGD (0.57) | HPGDSMN1; SMN2TSHRHDAC2HDAC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-120197417-A | Method for calculating clearance of radial bearing at lower part of main pump | 江苏核电有限公司 | 2025-06-24 | — | — | CN | claimed |
| EP-4575488-A2 | METHODS FOR CHROMATOGRAPHY DATA ANALYSIS | Regeneron Pharmaceuticals, Inc. (US) | 2025-06-25 | — | — | EP | disclosed |
| CN-120197417-A | Method for calculating clearance of radial bearing at lower part of main pump | 江苏核电有限公司 | 2025-06-24 | — | — | CN | disclosed |
| CN-120197417-A | Method for calculating clearance of radial bearing at lower part of main pump | 江苏核电有限公司 | 2025-06-24 | — | — | CN | disclosed |
| EP-4071469-B1 | METHODS FOR CHROMATOGRAPHY DATA ANALYSIS | REGENERON PHARMA (US) | 2025-04-09 | — | — | EP | disclosed |
| WO-2025055194-A1 | GENETICALLY ENGINEERED BACTERIUM FOR DE NOVO SYNTHESIS OF VANILLIN USING GLUCOSE AS SUBSTRATE, AND USE THEREOF | 北京化工大学 | 2025-03-20 | — | — | WO | disclosed |
| EP-4524234-A1 | GENETICALLY ENGINEERED BACTERIUM USING GLUCOSE AS SUBSTRATE FOR DE NOVO SYNTHESIS OF VANILLIN AND APPLICATION THEREOF | Beijing University Of Chemical Technology (CN) | 2025-03-19 | — | — | EP | disclosed |
| CN-119361160-A | Expert rule-based low-molecular heparin accurate drug delivery decision system and method | 吉林大学第一医院 | 2025-01-24 | — | — | CN | disclosed |
| US-20240318209-A1 | GENETICALLY ENGINEERED BACTERIUM USING GLUCOSE AS SUBSTRATE FOR DE NOVO SYNTHESIS OF VANILLIN AND APPLICATION THEREOF | BEIJING UNIVERSITY OF CHEMICAL TECHNOLOGY (CN) | 2024-09-26 | — | — | US | disclosed |
| CN-117004544-B | Genetically engineered bacterium for synthesizing vanillin from head by taking glucose as substrate and application thereof | 北京化工大学 | 2023-12-12 | — | — | CN | disclosed |
| US-11600045-B2 | Collaborative light show authoring for tessellated geometries | CONTRAVENTUM, LLC (US) | 2023-03-07 | — | — | US | disclosed |
| CN-218058010-U | Non-contact input device with air humidifying and sterilizing functions | 浙江警官职业学院 | 2022-12-16 | — | — | CN | disclosed |
| US-20220366648-A1 | Collaborative Light Show Authoring for Tessellated Geometries | CONTRAVENTUM, LLC (US) | 2022-11-17 | — | — | US | disclosed |
| EP-4071469-A2 | METHODS AND SYSTEMS FOR CHROMATOGRAPHY DATA ANALYSIS | Regeneron Pharmaceuticals, Inc. (US) | 2022-10-12 | — | — | EP | disclosed |
| US-20220308025-A1 | METHODS AND SYSTEMS FOR CHROMATOGRAPHY DATA ANALYSIS | REGENERON PHARMACEUTICALS, INC. (US) | 2022-09-29 | — | — | US | disclosed |
| CN-114858957-A | Method and system for chromatographic data analysis | 里珍纳龙药品有限公司 | 2022-08-05 | — | — | CN | disclosed |
| EP-3532838-B1 | METHODS AND SYSTEMS FOR CHROMATOGRAPHY DATA ANALYSIS | REGENERON PHARMA (US) | 2022-06-01 | — | — | EP | disclosed |
| CN-109923411-B | Method and system for chromatographic data analysis | 里珍纳龙药品有限公司 | 2022-05-31 | — | — | CN | disclosed |
| US-11333642-B2 | Methods and systems for chromatography data analysis | Regeneran Pharmaceuticals, Inc. (US) | 2022-05-17 | — | — | US | disclosed |
| US-11282276-B2 | Collaborative light show authoring for tessellated geometries | CONTRAVENTUM, LLC (US) | 2022-03-22 | — | — | US | disclosed |